Skip to content
TREVENTIS™ Corporation
  • Home
  • About Us
    • Board of Directors
    • Advisory Board
  • Pipeline
    • Dual Aβ/ tau oligomer inhibitor
    • Broad spectrum TDP oligomer inhibitor
    • p53 oligomer inhibitor
  • Technology
    • Protein Misfolding: The Basics
    • Treventis’ CCM Technology
  • Therapeutic Areas
    • Alzheimer’s Disease and Tauopathy
    • Amyotrophic Lateral Sclerosis (ALS)
    • Parkinson’s Disease
    • Cancer
  • News & Publications
    • News
    • Publications
    • Social Media
  • Careers
  • Partners & Collaborators
  • Contact Us
TREVENTIS™ Corporation
TREVENTISTM Corporation > News & Publications > News > Treventis Diagnostics highlighted in recent press articles
  • Share
             
  • Print

Treventis Diagnostics highlighted in recent press articles

The Treventis diagnostics program, headed by neurologist and medicinal chemist Dr. Sultan Darvesh, was recently featured in two news articles:

http://www.nshealth.ca/news/creating-worlds-first-definitive-diagnostic-test-alzheimers-disease

https://www.dal.ca/news/2018/01/10/sultan-darvesh–revolutionary-researcher.html?utm_source=Today@Dal&utm_medium=email&utm_campaign=dalnews

Print

Post navigation

TREVENTIS becomes a resident of JLABS @ Toronto
Treventis scientists attend Alzheimer Association International Conference
  • News
  • Publications
  • Social Media

Quick Links

  • Home
  • About Us
  • Contact Us

Social Links

  • Twitter
  • Linkedin
Copyright © Treventis Corporation. | Site Map
Website by Axxiem